• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Anthera Pharmaceuticals, Inc. (ANTH)

    1.58 Up 0.10(6.76%) Dec 26, 3:53PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Anthera Pharmaceuticals, Inc.
    25801 Industrial Boulevard
    Suite B
    Hayward, CA 94545
    United States - Map
    Phone: 510-856-5600
    Fax: 510-856-5597
    Website: http://www.anthera.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:25

    Business Summary 

    Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing products to treat diseases associated with inflammation and autoimmune diseases. It is developing blisibimod, a Phase III product candidate that targets elevated levels of B-cell activating factor associated with various B-cell mediated autoimmune diseases, including systemic lupus erythematosus, IgA nephropathy, lupus nephritis, multiple myeloma, vasculitis, idiopathic thrombocytopenia purpura, and others. The company was founded in 2004 and is headquartered in Hayward, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Anthera Pharmaceuticals, Inc.

    Key Executives 
    Mr. Paul F. Truex MBA, 45
    Chief Exec. Officer, Pres and Director
    Ms. May Liu , 38
    Sr. VP of Fin. & Admin., Principal Accounting Officer and Compliance Officer
    Dr. Debra Odink Ph.D., 50
    Chief Technology Officer and Sr. VP
    Dr. Colin Hislop M.D., 56
    Chief Medical Officer and Sr. VP
    Dr. Paul Adams Ph.D., 51
    Sr. VP of Global Regulatory Affairs and Compliance
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders